The world of drug royalties financing

Asian healthcare specialist CBC Group believes specialised debt funds focused on pharma products can be complementary to equity investments.

ByCarmela Mendoza

1 November 2023•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Featured Healthcare Manager strategy Private debt

Related articles

alt

Inside PEI Group's inaugural Private Markets 100 ranking

8 October 2026 · 1 min read

alt

Private market relationships take new shape, says Davis Polk

5 October 2026 · 8 mins read

alt

Women of Influence: Leading the way

5 October 2026 · 1 min read

alt

Download Private Equity International’s 2026 Women in Private Funds report

5 October 2026 · 1 min read

alt

The governance blind spot in the Total Portfolio Approach

1 October 2026 · 2 mins read

alt

Download PEI’s 2026 Operational Excellence report

1 October 2026 · 1 min read

alt

Inside IVEST and Cloverlay’s early Care Bears exit

1 October 2026 · 4 mins read

motif